<html>
<head>PUBMED IDs for TRIP13</head>
<body bgcolor='#C5F0F2'><h1>TRIP13</h1><a href='https://pubmed.ncbi.nlm.nih.gov/18328944/'>Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer.</a> March 11  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/22513784/'>A meta-analysis of gene expression data identifies a molecular signature characteristic for tumor-stage mycosis fungoides.</a> October 2  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22513782/'>A promiscuous survivin-derived T-cell epitope restricted to the HLA-A3 super-type alleles.</a> October 2  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/25012665/'>Thyroid hormone receptor interacting protein 13 (TRIP13) AAA-ATPase is a novel mitotic checkpoint-silencing protein.</a> December 17  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25078033/'>TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer.</a> November 3  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25078021/'>Multistable switches and their role in cellular differentiation networks.</a> October 2  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25635513/'>PCH-2 regulates Caenorhabditis elegans lifespan.</a> July 25  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25918846/'>TRIP13 is a protein-remodeling AAA+ ATPase that catalyzes MAD2 conformation switching.</a> January 15  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26324890/'>Mode of interaction of TRIP13 AAA-ATPase with the Mad2-binding protein p31comet and with mitotic checkpoint complexes.</a> December 29  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26527623/'>Translating Proteomic Into Functional Data: An High Mobility Group A1 (HMGA1) Proteomic Signature Has Prognostic Value in Breast Cancer.</a> October 12  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26832417/'>TRIP13 Regulates Both the Activation and Inactivation of the Spindle-Assembly Checkpoint.</a> November 2  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28157697/'>TRIP13 impairs mitotic checkpoint surveillance and is associated with poor prognosis in multiple myeloma.</a> February 4  2017<br></body></html>
